CVE-2024-1097

MEDIUM
Published Nov 15, 2024 Modified Nov 19, 2024 CWE-79

Description

A stored cross-site scripting (XSS) vulnerability exists in craigk5n/webcalendar version 1.3.0. The vulnerability occurs in the 'Report Name' input field while creating a new report. An attacker can inject malicious scripts, which are then executed in the context of other users who view the report, potentially leading to the theft of user accounts and cookies.

Is your site exposed to CVE-2024-1097?

Run a free security scan — no signup, results in seconds.

CVSS v3.1 Score

5.4
MEDIUM
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Weakness Type (CWE)

CWE-79 Cross-site Scripting (XSS)

Affected Products

Vendor Product
k5n webcalendar

References

Frequently Asked Questions

What is CVE-2024-1097? +
A stored cross-site scripting (XSS) vulnerability exists in craigk5n/webcalendar version 1.3.0. The vulnerability occurs in the 'Report Name' input field while creating a new report. An attacker can inject malicious scripts, which are then executed in the context of other users who view the report, potentially leading to the theft of user accounts and cookies. It has a CVSS v3.1 base score of 5.4 (MEDIUM).
How severe is CVE-2024-1097? +
CVE-2024-1097 has a CVSS v3.1 score of 5.4 out of 10, rated MEDIUM. This is a medium-severity vulnerability that should be remediated as part of regular maintenance.
What products are affected by CVE-2024-1097? +
CVE-2024-1097 affects products from k5n, specifically: webcalendar. Check the affected products table above for specific version ranges.
How do I check if I'm vulnerable to CVE-2024-1097? +
You can use Secably's free Website Scanner to check your website for known vulnerabilities. For infrastructure scanning, use the Port Scanner to identify exposed services that may be affected. Check the vendor advisories linked above for specific patch and version information.

Related Vulnerabilities

Don't wait for an exploit

Scan your website for vulnerabilities like CVE-2024-1097 — free, no signup required.